Invivyd, Inc. (IVVD)
0.4479
0.00 (0.00%)
USD |
NASDAQ |
Nov 20, 09:49
Invivyd Free Cash Flow : -134.11M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -134.11M |
| June 30, 2026 | -109.66M |
| March 31, 2026 | -79.46M |
| December 31, 2025 | -58.29M |
| September 30, 2025 | -80.44M |
| June 30, 2025 | -113.26M |
| March 31, 2025 | -141.55M |
| December 31, 2024 | -170.63M |
| September 30, 2024 | -192.27M |
| June 30, 2024 | -186.54M |
| March 31, 2024 | -182.33M |
| Date | Value |
|---|---|
| December 31, 2023 | -173.78M |
| September 30, 2023 | -163.15M |
| June 30, 2023 | -184.42M |
| March 31, 2023 | -204.45M |
| December 31, 2022 | -221.69M |
| September 30, 2022 | -246.37M |
| June 30, 2022 | -243.97M |
| March 31, 2022 | -220.13M |
| December 31, 2021 | -184.82M |
| September 30, 2021 | -124.95M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lineage Cell Therapeutics, Inc. | -26.46M |
| Armata Pharmaceuticals, Inc. | -26.86M |
| Voyager Therapeutics, Inc. | -109.83M |
| Black Diamond Therapeutics, Inc. | -33.32M |
| Elicio Therapeutics, Inc. | -36.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.11M |
| Cash from Investing (Quarterly) | -0.585M |
| Cash from Financing (Quarterly) | 0.028M |
| Free Cash Flow Per Share (Quarterly) | -0.1014 |
| Free Cash Flow to Equity (Quarterly) | -32.56M |
| Free Cash Flow to Firm (Quarterly) | -32.70M |
| Free Cash Flow Yield | -101.3% |